NRF invests $50m in Liontown Resources for lithium production


Tuesday, 12 August, 2025

NRF invests $50m in Liontown Resources for lithium production

The National Reconstruction Fund (NRF) last week announced a $50 million equity investment in Liontown Resources to support the ramp-up and underground transition of the company’s Kathleen Valley Lithium Operation.

Liontown Resources is a key supplier of lithium to some of the world's leading vehicle and battery manufacturers, including Tesla, Ford, and LG Energy Solution, and is paving the way for downstream lithium processing in Australia.

The federal government said the NRF’s $50 million equity investment in Liontown underscores its commitment to advancing Australia’s mineral refining capabilities and strengthening critical supply chains.

The government said the investment is a key example of its Future Made in Australia agenda, which aims to build a more capable, productive and resilient economy.

“I am delighted by today’s announcement, and to see the National Reconstruction Fund backing the critical minerals supply chain,” said Minister for Industry and Innovation and Minister for Science Tim Ayres. “With Australia’s critical and abundant natural endowments, like lithium, and skilled workers, Australia is well positioned to strengthen supply chains and become an indispensable part of the low-carbon global economy.”

“Liontown at Kathleen Valley is a world leading example of sustainable lithium spodumene mining that Australians should be proud to be a part of through this NRF contribution,” said Minister for Resources, Madeleine King.

Image credit: Liontown Resources.

Related News

Construction begins on Eyre Peninsula desalination project

Key contractors announced as desalination project moves forward.

Nexobot wins Australia's first robotics sprint

Melbourne-based Nexobot has been named the winner of Australia's inaugural Propel-AIR...

Queensland bio‍manufacturing facility nearing completion

The Translational Research Institute (TRI) will soon open a cGMP biomedical manufacturing...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd